Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer discovery

Showing results (1-10 of 4,665) with videos related to

Pageof 467
Sort By:
Cancer Discovery|June 10, 2022
Engineered KRAS G12D-Reactive T Cells Show Promise in Pancreatic Cancer
Cancer Discovery|June 10, 2022
Antitumor Immunity Is Induced by Exercise in Pancreatic Cancer
Cancer Discovery|June 10, 2022
Glimmers of Hope for Targeting p53
Cancer Discovery|June 9, 2019
"Super Trastuzumab" Extends PFS in Late-Line Breast Cancer
Cancer Discovery|June 23, 2019
Colon Cancer Data Key as Pfizer Buys Array
Cancer Discovery|June 23, 2019
V211D Mutation in MEK1 Causes Resistance to MEK Inhibitors in Colon CancerYijun Gao, Ann Maria, Na Na, et al.
Cancer Discovery|October 17, 2018
Charities Fund UK-EU Research Partnerships
Cancer Discovery|June 21, 2019
BRAF/MEK Combo Active across Tumor Types
Cancer Discovery|July 27, 2016
Toward Better Oversight of NGS Tests
Cancer Discovery|April 22, 2015
Pembrolizumab Shows Promise for NSCLC
Pageof 467

Showing results (1-10 of 4,665) with videos related to

Sort By:
Pageof 467
Cancer Discovery|June 10, 2022
Engineered KRAS G12D-Reactive T Cells Show Promise in Pancreatic Cancer
Cancer Discovery|June 10, 2022
Antitumor Immunity Is Induced by Exercise in Pancreatic Cancer
Cancer Discovery|June 10, 2022
Glimmers of Hope for Targeting p53
Cancer Discovery|June 9, 2019
"Super Trastuzumab" Extends PFS in Late-Line Breast Cancer
Cancer Discovery|June 23, 2019
Colon Cancer Data Key as Pfizer Buys Array
Cancer Discovery|June 23, 2019
V211D Mutation in MEK1 Causes Resistance to MEK Inhibitors in Colon CancerYijun Gao, Ann Maria, Na Na, et al.
Cancer Discovery|October 17, 2018
Charities Fund UK-EU Research Partnerships
Cancer Discovery|June 21, 2019
BRAF/MEK Combo Active across Tumor Types
Cancer Discovery|July 27, 2016
Toward Better Oversight of NGS Tests
Cancer Discovery|April 22, 2015
Pembrolizumab Shows Promise for NSCLC
Pageof 467